Transfer of a Heart Disease Treatment Analysis from an Agilent 1100 System to an UltiMate 3000 HPLC System

Significance of the Topic

Analytical laboratories frequently need to migrate established HPLC methods between different instrument platforms while maintaining separation quality. Gradient methods are particularly sensitive to variations in fluidics and gradient delay volume, which can affect retention time accuracy, peak shape, and resolution.

Objectives and Study Overview

This work demonstrates the seamless transfer of a gradient HPLC method for a set of cardiovascular drugs from an Agilent 1100 system to a Thermo Scientific UltiMate 3000 system. The aim was to match retention times and chromatographic performance with minimal method adjustment.

Methodology and Instrumentation

• Analytes: Hydrochlorothiazide, chlorthalidone, enalapril, an impurity, ramipril, telmisartan, azilsartan, valsartan.
• Column: C18, 4.6×150 mm, 4 µm.
• Mobile phase A: Water + 0.1% formic acid; B: Methanol + 0.07% formic acid.
• Gradient: 90% A to 20% A over 10 min, hold 1.5 min, return to 90% A at 12 min, equilibrate to 17 min.
• Flow rate: 1.2 mL/min; Temperature: 50 °C; Injection volume: 25 µL; Detection: UV at 214 nm; Data rate: 10 Hz.

Used Instrumentation

• Agilent 1100: G1322A degasser, G1311A QuatPump, G1367A autosampler, G1315A DAD.
• UltiMate 3000 SD: SRD-3400 degasser, LPG-3400SD pump, WPS-3000TSL autosampler, DAD-3000 detector.
• Mixers: Default 350 µL; optimized 800 µL SpinFlow™ mixer.
• Software: Chromeleon 7.2 CDS.

Main Results and Discussion

With default hardware, the UltiMate 3000 yielded earlier elution and sharper peaks due to reduced gradient delay volume. Fitting an 800 µL mixer brought retention times within 0.06 min for most analytes (0.19 min for the first peak). Peak height increased 3–98%, width at half height decreased 10–19%, and resolution improved up to 36%.

Benefits and Practical Applications

The transfer requires only mixer adjustment, offering a rapid way to replicate legacy method performance on newer instrumentation. Improved peak shape and resolution enhance sensitivity and reproducibility in routine QA/QC and research of cardiovascular compounds.

Future Trends and Opportunities

Further enhancements may include customizing pre-heater volumes and extra-column contributions to refine isocratic segments. Ongoing advances in microfluidics, mixer design, and AI-driven method development promise even faster, more robust transfers across diverse HPLC platforms.

Conclusion

A gradient separation for heart disease medications was effectively migrated from an Agilent 1100 to an UltiMate 3000 system. By installing an 800 µL mixer, retention times and peak profiles closely matched or exceeded original performance, illustrating a straightforward transfer strategy.

References

1. Steiner F. UHPLC: Analyzing Complex Samples Faster — Practical Considerations for Maximizing Performance and Productivity in UHPLC. GIT Laboratory Journal. 2014.
2. Bailey B, Gamache P, Acworth I. Guidelines for Method Transfer and Optimization from Earlier Corona Detectors to Corona Veo. Thermo Fisher Scientific Technical Note. 2014.
3. Krull I, Swartz M. Analytical Method Transfer. LCGC. 2006.
4. Thermo Scientific. Reliable Solvent Mixing in UHPLC. Technical Note 108. 2011.